GURUFOCUS.COM » STOCK LIST » Industrials » Aerospace & Defense » Lisi SA (XPAR:FII) » Definitions » COGS-to-Revenue

Lisi (XPAR:FII) COGS-to-Revenue : 0.51 (As of Dec. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Lisi COGS-to-Revenue?

Lisi's Cost of Goods Sold for the six months ended in Dec. 2023 was €436 Mil. Its Revenue for the six months ended in Dec. 2023 was €857 Mil.

Lisi's COGS to Revenue for the six months ended in Dec. 2023 was 0.51.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Lisi's Gross Margin % for the six months ended in Dec. 2023 was 49.11%.


Lisi COGS-to-Revenue Historical Data

The historical data trend for Lisi's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lisi COGS-to-Revenue Chart

Lisi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.48 0.47 0.50 0.52

Lisi Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.50 0.50 0.54 0.51

Lisi COGS-to-Revenue Calculation

Lisi's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=879.178 / 1678.345
=0.52

Lisi's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=435.88 / 856.58
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lisi  (XPAR:FII) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Lisi's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 435.88 / 856.58
=49.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Lisi COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lisi's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Lisi (XPAR:FII) Business Description

Traded in Other Exchanges
Address
6 Rue Juvenal Viellard, Grandvillars, Belfort Cedex, CS 70431, Belfort, FRA, 90008
Lisi SA primarily designs, manufactures, and markets fasteners and other components for the aerospace and vehicular sectors. The company has three operating segments: Aerospace, Automotive, and Medical. Products are manufactured to serve as original or replacement equipment. They are distributed internationally and may undergo customization for Lisi's major clients. The Medical segment creates fasteners, implants, and other instruments to help support the human body, and is responsible for roughly 5% of sales. France accounts for roughly one third of sales, European Union accounts for another one third of sales, and the rest of the world makes up the remainder.

Lisi (XPAR:FII) Headlines

No Headlines